# Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma

> **NCT05978284** · PHASE1,PHASE2 · RECRUITING · sponsor: **Suzhou Zelgen Biopharmaceuticals Co.,Ltd** · enrollment: 54 (estimated)

## Conditions studied

- Small Cell Lung Cancer
- Neuroendocrine Carcinoma

## Interventions

- **BIOLOGICAL:** ZG006

## Key facts

- **NCT ID:** NCT05978284
- **Lead sponsor:** Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-27
- **Primary completion:** 2026-09
- **Final completion:** 2026-10
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05978284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05978284, "Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05978284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*